Namisaki T - Search Results

1

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

Okura Y, Namisaki T, Moriya K, Kitade M, Takeda K, Kaji K, Noguchi R, Nishimura N, Seki K, Kawaratani H, Takaya H, Sato S, Sawada Y, Shimozato N, Furukawa M, Nakanishi K, Saikawa S, Kubo T, Asada K, Yoshiji H. Okura Y, et al. Among authors: namisaki t. Hepatol Res. 2017 Nov;47(12):1317-1328. doi: 10.1111/hepr.12860. Epub 2017 Feb 13. Hepatol Res. 2017. PMID: 28029729

2

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H. Yoshiji H, et al. Among authors: namisaki t. Hepatology. 2002 Oct;36(4 Pt 1):850-60. doi: 10.1053/jhep.2002.35625. Hepatology. 2002. PMID: 12297832

3

Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model.

Ikenaka Y, Yoshiji H, Kuriyama S, Yoshii J, Noguchi R, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Masaki T, Fukui H. Ikenaka Y, et al. Among authors: namisaki t. Int J Cancer. 2003 Jun 20;105(3):340-6. doi: 10.1002/ijc.11094. Int J Cancer. 2003. PMID: 12704667

4

Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Fukui H. Yoshiji H, et al. Among authors: namisaki t. Oncol Rep. 2003 Jul-Aug;10(4):957-62. Oncol Rep. 2003. PMID: 12792752

5

The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Fukui H. Yoshiji H, et al. Among authors: namisaki t. Oncol Rep. 2003 Sep-Oct;10(5):1369-73. Oncol Rep. 2003. PMID: 12883709

6

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Masaki T, Fukui H. Yoshiji H, et al. Among authors: namisaki t. Gut. 2003 Sep;52(9):1347-54. doi: 10.1136/gut.52.9.1347. Gut. 2003. PMID: 12912869 Free PMC article.

7

Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Fukui H. Yoshiji H, et al. Among authors: namisaki t. Hepatol Res. 2003 Sep;27(1):51-56. doi: 10.1016/s1386-6346(03)00160-8. Hepatol Res. 2003. PMID: 12957207

8

Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

Noguchi R, Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Mitoro A, Tsujinoue H, Imazu H, Masaki T, Fukui H. Noguchi R, et al. Among authors: namisaki t. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6038-45. Clin Cancer Res. 2003. PMID: 14676130

9

Successful treatment of acute Budd-Chiari syndrome with percutaneous transluminal angioplasty.

Shirai Y, Yoshiji H, Fujimoto M, Kojima H, Yanase K, Namisaki T, Kitade M, Yamamoto K, Sakaguchi H, Kichikawa K, Fukui H. Shirai Y, et al. Among authors: namisaki t. Abdom Imaging. 2004 Nov-Dec;29(6):685-7. doi: 10.1007/s00261-004-0183-6. Epub 2004 Jun 8. Abdom Imaging. 2004. PMID: 15185028

10

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H, Masaki T, Fukui H. Yoshiji H, et al. Among authors: namisaki t. Hepatology. 2004 Jun;39(6):1517-24. doi: 10.1002/hep.20218. Hepatology. 2004. PMID: 15185292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters